Literature DB >> 32876046

Identification of protein-protected mRNA fragments and structured excised intron RNAs in human plasma by TGIRT-seq peak calling.

Jun Yao1, Douglas C Wu1, Ryan M Nottingham1, Alan M Lambowitz1.   

Abstract

Human plasma contains > 40,000 different coding and non-coding RNAs that are potential biomarkers for human diseases. Here, we used thermostable group II intron reverse transcriptase sequencing (TGIRT-seq) combined with peak calling to simultaneously profile all RNA biotypes in apheresis-prepared human plasma pooled from healthy individuals. Extending previous TGIRT-seq analysis, we found that human plasma contains largely fragmented mRNAs from > 19,000 protein-coding genes, abundant full-length, mature tRNAs and other structured small non-coding RNAs, and less abundant tRNA fragments and mature and pre-miRNAs. Many of the mRNA fragments identified by peak calling correspond to annotated protein-binding sites and/or have stable predicted secondary structures that could afford protection from plasma nucleases. Peak calling also identified novel repeat RNAs, miRNA-sized RNAs, and putatively structured intron RNAs of potential biological, evolutionary, and biomarker significance, including a family of full-length excised intron RNAs, subsets of which correspond to mirtron pre-miRNAs or agotrons.
© 2020, Yao et al.

Entities:  

Keywords:  RNA-binding protein; biomarker; cell-free RNA; chromosomes; diagnostics; gene expression; human; miRNA; tRNA fragment

Mesh:

Substances:

Year:  2020        PMID: 32876046      PMCID: PMC7518892          DOI: 10.7554/eLife.60743

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  96 in total

1.  Regulated capture by exosomes of mRNAs for cytoplasmic tRNA synthetases.

Authors:  Feng Wang; Zhiwen Xu; Jie Zhou; Wing-Sze Lo; Ching-Fun Lau; Leslie A Nangle; Xiang-Lei Yang; Mingjie Zhang; Paul Schimmel
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

Review 2.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

3.  PhastWeb: a web interface for evolutionary conservation scoring of multiple sequence alignments using phastCons and phyloP.

Authors:  Ritika Ramani; Katie Krumholz; Yi-Fei Huang; Adam Siepel
Journal:  Bioinformatics       Date:  2019-07-01       Impact factor: 6.937

Review 4.  Cell-free nucleic acids as biomarkers in cancer patients.

Authors:  Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2011-05-12       Impact factor: 60.716

5.  Translational coregulation of 5'TOP mRNAs by TIA-1 and TIAR.

Authors:  Christian Kroun Damgaard; Jens Lykke-Andersen
Journal:  Genes Dev       Date:  2011-10-01       Impact factor: 11.361

6.  Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis.

Authors:  Qu Lin; Chu-Ren Zhou; Ming-Jun Bai; Duo Zhu; Jun-Wei Chen; Hao-Fan Wang; Ming-An Li; Chun Wu; Zheng-Ran Li; Ming-Sheng Huang
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

7.  Characterization of extracellular circulating microRNA.

Authors:  Andrey Turchinovich; Ludmila Weiz; Anne Langheinz; Barbara Burwinkel
Journal:  Nucleic Acids Res       Date:  2011-05-24       Impact factor: 16.971

8.  Infernal 1.1: 100-fold faster RNA homology searches.

Authors:  Eric P Nawrocki; Sean R Eddy
Journal:  Bioinformatics       Date:  2013-09-04       Impact factor: 6.937

9.  Detection of expanded RNA repeats using thermostable group II intron reverse transcriptase.

Authors:  Samuel T Carrell; Zhenzhi Tang; Sabine Mohr; Alan M Lambowitz; Charles A Thornton
Journal:  Nucleic Acids Res       Date:  2018-01-09       Impact factor: 16.971

10.  Distinct mechanisms of microRNA sorting into cancer cell-derived extracellular vesicle subtypes.

Authors:  Morayma M Temoche-Diaz; Matthew J Shurtleff; Ryan M Nottingham; Jun Yao; Raj P Fadadu; Alan M Lambowitz; Randy Schekman
Journal:  Elife       Date:  2019-08-22       Impact factor: 8.140

View more
  6 in total

1.  TGIRT-seq Protocol for the Comprehensive Profiling of Coding and Non-coding RNA Biotypes in Cellular, Extracellular Vesicle, and Plasma RNAs.

Authors:  Hengyi Xu; Ryan M Nottingham; Alan M Lambowitz
Journal:  Bio Protoc       Date:  2021-12-05

2.  Cancer type classification using plasma cell-free RNAs derived from human and microbes.

Authors:  Shanwen Chen; Yunfan Jin; Siqi Wang; Shaozhen Xing; Yingchao Wu; Yuhuan Tao; Yongchen Ma; Shuai Zuo; Xiaofan Liu; Yichen Hu; Hongyan Chen; Yuandeng Luo; Feng Xia; Chuanming Xie; Jianhua Yin; Xin Wang; Zhihua Liu; Ning Zhang; Zhenjiang Zech Xu; Zhi John Lu; Pengyuan Wang
Journal:  Elife       Date:  2022-07-11       Impact factor: 8.713

3.  Identification of protein-protected mRNA fragments and structured excised intron RNAs in human plasma by TGIRT-seq peak calling.

Authors:  Jun Yao; Douglas C Wu; Ryan M Nottingham; Alan M Lambowitz
Journal:  Elife       Date:  2020-09-02       Impact factor: 8.140

4.  Circulating SNORD57 rather than piR-54265 is a promising biomarker for colorectal cancer: common pitfalls in the study of somatic piRNAs in cancer.

Authors:  Juan Pablo Tosar; María Rosa García-Silva; Alfonso Cayota
Journal:  RNA       Date:  2020-12-29       Impact factor: 4.942

5.  Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin.

Authors:  Rosanne E Veerman; Loes Teeuwen; Paulo Czarnewski; Gözde Güclüler Akpinar; AnnSofi Sandberg; Xiaofang Cao; Maria Pernemalm; Lukas M Orre; Susanne Gabrielsson; Maria Eldh
Journal:  J Extracell Vesicles       Date:  2021-07-22

6.  Chemical capping improves template switching and enhances sequencing of small RNAs.

Authors:  Madalee G Wulf; Sean Maguire; Nan Dai; Alice Blondel; Dora Posfai; Keerthana Krishnan; Zhiyi Sun; Shengxi Guan; Ivan R Corrêa
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.